Connect with us


General adult population Covid-19 vaccination begins



The vaccination of the general adult population against Covid-19 in the Philippines has already started, the Department of Health (DoH) said Monday.

“We are now announcing the start of the Covid-19 vaccination of the general adult population,” Health undersecretary Maria Rosario Vergeire said in a virtual media forum.

Vergeire said that the vaccine cluster assured that the country has enough supply of Covid-19 vaccines for the inclusion of the general adult population amid the inoculation of children with comorbidities which will start on Friday.

The official said the operational guidelines for the vaccination of the general adult population are based on the resolution of the Inter-Agency Task Force against Emerging Infectious Diseases and a memorandum from the DoH.

Despite another inclusion of a new sector in the vaccine prioritization list, Vergeire said the local government units should still prioritize the vaccination of senior citizens and those with comorbidities.

“We want to call on local government units to create special or dedicated lanes for senior citizens and persons with comorbidities because they are more vulnerable to severe symptoms,” she said.

Asked whether the walk-ins or registration is still needed, the official said it is up to the local governments.


Vaccination of minors with comorbidities

Meanwhile, Vergeire assured the public that the government is ready for the vaccination of children with comorbidities.

She said the government has already prepared for the logistics, as well as the capacity to monitor adverse effects.

“If you will ask us if we are prepared, they are prepared in terms of technical capacity, yes, we have that capacity to detect and manage these kinds of reactions,” she said.

“We do not need to worry, the government will not give the vaccine if it’s bad for children. Let us remember that if it is being given, the benefit outweighs the risks,” she added.

The agency previously said that children with comorbidities will be administered vaccines with mRNA platforms such as Pfizer and Moderna.